Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Clin Neuropsychol. 2017 Jan 12;31(8):1375–1386. doi: 10.1080/13854046.2016.1275819

Table 1.

Demographic and clinical characteristics

Variable HC (n = 27) BC (n = 26)
Age of patient at time of assessment, yrs, mean (SD)a* 65.07 (8.57) 60.81 (5.59)
Race/Ethnicityb*
 White/Caucasian, n (%) 22 (81.5%) 14 (53.8%)
 Non-White/Caucasian, n (%) 5 (18.5%) 12 (46.2%)
Years of education, mean (SD) 14.67 (1.55) 14.35 (1.79)
Body mass index, mean (SD) 28.79 (6.75) 29.19 (5.10)
Charlson Comorbidity Index, mean (SD) 0.59 (0.75) 0.81 (0.90)
Brief Symptom Inventory, mean (SD)c* 42 (7.6) 49 (10.5)
Functional Activities Questionnaire, mean (SD)d 0.44 (0.94) 1.77 (4.45)

HC=Healthy Controls; BC=Breast Cancer

a

t(51) = 2.14, p = .037

b

χ2 = 4.64, p = .031

c

t(51) = 2.45, p = .005

d

t(51) = −1.53, p = .135

*

p < .05